Yale University
Glycemic control is often the main indicator of successful diabetes care, but a singular focus on glycemic control may lead to patients' overall health and wellbeing being overlooked or undervalued. The investigators have previously developed an intervention comprised of (a) a set of conversation cards designed to enable patients to identify aspects of life with diabetes important to them and to share them with their clinician to obtain their input; and (b) materials that help clinicians respond to patient concerns. The investigators will now conduct a randomized clinical trial to test the feasibility of the research procedures and efficacy of the intervention with respect to patient reported outcome measures.
Type 2 Diabetes
Diabetes
QBSafe
Not Applicable
The goal of this study is to assess the feasibility and efficacy of usual care with the QBSafe intervention compared to usual care alone within a cluster randomized clinical trial among patients with type 2 diabetes.}}
| Study Type : | Interventional |
| Estimated Enrollment : | 164 participants |
| Masking : | None (Open Label) |
| Primary Purpose : | Supportive Care |
| Official Title : | QBSafe: a Randomized Trial of a Novel Intervention to Improve Care for People Living With Type 2 Diabetes. |
| Actual Study Start Date : | November 2, 2022 |
| Estimated Primary Completion Date : | January 2025 |
| Estimated Study Completion Date : | March 2025 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: QBSafe intervention |
|
|
No Intervention: usual care |
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Fair Haven Community Health Center
New Haven, Connecticut, United States, 06510